Motrin and Advil are two of the most widely used over-the-counter (OTC) pain relievers. Both medications contain ibuprofen, an anti-inflammatory drug that works to reduce pain, fever, and inflammation. While both medications are effective in treating these symptoms, there are some differences between them that doctors should be aware of when recommending one over the other. This article will provide a comprehensive comparison of Motrin and Advil, including their active ingredients, dosage forms, side effects, and contraindications.
The active ingredient in both Motrin and Advil is ibuprofen. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking the production of certain chemicals in the body that cause pain and inflammation. Ibuprofen is available in both over-the-counter and prescription strengths. The active ingredient in Motrin is ibuprofen lysine, while the active ingredient in Advil is ibuprofen sodium. The difference between the two is that ibuprofen lysine is slightly more soluble in water than ibuprofen sodium, which means it is absorbed faster into the bloodstream.
Motrin and Advil are both available in a variety of dosage forms, including tablets, capsules, liquids, and gels. Motrin is also available as an oral suspension, while Advil is available as an oral suspension and a chewable tablet. The recommended dosages for Motrin and Advil vary depending on the age and weight of the patient. Generally, the recommended dose for adults is 200-400mg every 4-6 hours, not exceeding 1200mg per day. For children, the recommended dose is 10-15mg/kg/day, divided into 3-4 doses.
The most common side effects of Motrin and Advil are nausea, stomach pain, and diarrhea. Other potential side effects include dizziness, headache, drowsiness, and rash. In some cases, these medications can cause more serious side effects, such as liver or kidney damage, or an allergic reaction. If any of these side effects occur, the patient should seek medical attention immediately.
Motrin and Advil should not be used in patients with a known allergy to ibuprofen, or those with a history of stomach ulcers, kidney or liver disease, or bleeding disorders. In addition, Motrin and Advil should not be used in combination with other NSAIDs, such as aspirin or naproxen, as this can increase the risk of side effects.
Motrin and Advil are two of the most commonly used OTC pain relievers. Both medications contain ibuprofen, an anti-inflammatory drug that works to reduce pain, fever, and inflammation. While both medications are effective in treating these symptoms, doctors should be aware of the differences between them, including their active ingredients, dosage forms, side effects, and contraindications. It is important for patients to follow the instructions on the medication packaging and seek medical attention if any side effects occur.
1.
According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.
2.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
3.
Vepdegestrant Earns FDA Nod for ESR1-Mutated Breast Cancer
4.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
5.
A new blood test greatly increases the ability to detect cancer.
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
Unraveling the Mysteries of Hematocrit: How It Impacts Your Health
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
5.
Surprising Symptoms of Prostate Cancer: What You Need to Know
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation